Document is current

Any future updates will be listed below

Specificity of Food and Drug Administration postmarketing requirements and associations with timely submissions and regulatory decisions for oncology accelerated approvals, 2011–2023: a cross-sectional analysis

Crossref DOI link: https://doi.org/10.1136/bmjonc-2024-000659

Published Online: 2025-05-19

Published Print: 2025-05

Update policy: https://doi.org/10.1136/crossmarkpolicy

About CrossMark